Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Creatine monohydrate

Drug Profile

Creatine monohydrate

Alternative Names: AL-02; AL-05; ALS-02; ALS-05; ALS-08/celecoxib; ALS-08/minocycline; CMT-02; CTD-02; CTD-09; DMD-02; HD-02; NEOtine; PD-01; PD-02; PD-04; PD-06; PURE ENERGY

Latest Information Update: 03 Jun 2010

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Avicena Group
  • Class Amino acids; Guanidines; Neuroprotectants; Small molecules
  • Mechanism of Action Mitochondrial protein stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Huntington's disease; Amyotrophic lateral sclerosis
  • New Molecular Entity No

Highest Development Phases

  • No development reported Amyotrophic lateral sclerosis; Huntington's disease; Metabolic disorders; Neuromuscular disorders; Parkinson's disease

Most Recent Events

  • 24 Jun 2018 Biomarkers information updated
  • 03 Jun 2010 No development reported - Phase-I for Neuromuscular disorders in USA (PO)
  • 03 Jun 2010 No development reported - Phase-II for Huntington's disease in USA (PO)
Restricted Access

If your organization has a subscription then there are several options available to help you access AdisInsight while working remotely. Contact us at AsktheExpert.AdisInsight@springer.com to find out more.
Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top